Reconstitution chart: 5 mg vial
| BAC water added | Concentration | Draw for 100 mcg dose | Draw for 300 mcg dose |
|---|---|---|---|
| 1 mL | 5,000 mcg/mL | 2 units | 6 units |
| 1.5 mL | 3,333 mcg/mL | 3 units | 9 units |
| 2 mL | 2,500 mcg/mL | 4 units | 12 units |
| 2.5 mL | 2,000 mcg/mL | 5 units | 15 units |
Draws are U-100 insulin syringe units (100 units = 1 mL). Formula: dose in mcg ÷ (vial mcg ÷ water mL) × 100. The calculator above handles any other combination.
About Ipamorelin
Ipamorelin is a synthetic pentapeptide that acts as a selective growth hormone secretagogue: it mimics ghrelin at its receptor and prompts the pituitary to release a pulse of growth hormone. It earned its following among research users for that selectivity, since older compounds in the class also spiked cortisol and hunger. It has no regulatory approval; clinical development was discontinued years ago without reaching market.
Online communities typically discuss 100 to 300 mcg per injection, taken one to three times daily, with the pre-bed dose considered the anchor because natural growth hormone release concentrates in early sleep. The half-life is short, around two hours, which is why discussion centers on multiple small doses rather than one large one. As always on this site, those numbers describe what communities discuss, never what you should do.
Ipamorelin is the most common blend partner for CJC-1295, and combination vials are everywhere. The math for a blend is unchanged: total peptide in the vial, total dose per injection. A 5 mg ipamorelin vial at 200 mcg per dose holds 25 doses, so a single vial often outlasts a month of the discussed schedules.
Quick facts
- Status: no regulatory approval; clinical development discontinued
- Half-life: roughly 2 hours, which is why discussion favors multiple small doses
- Community-discussed range: 100 to 300 mcg, one to three times daily
- Common vial sizes: 2, 5, and 10 mg; frequently blended with CJC-1295